Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Neuralgia × Thalidomide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 46 Neoplasms, Plasma Cell 18 Central Nervous System Neoplasms 10 Glioblastoma 9 Recurrence 8 Brain Neoplasms 8 Prostatic Neoplasms 7 Melanoma 7 Gliosarcoma 7 Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Leukemia 5 Glioma 5 Waldenstrom Macroglobulinemia 4 Sarcoma 4 Lung Neoplasms 4 Kidney Neoplasms 4 Colorectal Neoplasms 4 Carcinoma, Renal Cell 4 Carcinoma, Hepatocellular 4 Myeloproliferative Disorders 3 Myelodysplastic-Myeloproliferative Diseases 3 Myelodysplastic Syndromes 3 Lymphoma, B-Cell, Marginal Zone 3 Lymphoma 3 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3 Immunoglobulin Light-chain Amyloidosis 3 Colonic Neoplasms 3 Astrocytoma 3 Anemia, Refractory, with Excess of Blasts 3

Interventions

Pregabalin 3 ziconotide 1 Thalidomide 1 Telmisartan 1 Oxycodone 1 KRN 5500 1 Cholecalciferol 1 Capsaicin 1 Bupivacaine 1 Amitriptyline 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00284505 2008-12-05

Use of Thalidomide in Patients With Arachnoiditis

Washington University School of Medicine

Phase 2 Completed

Arachnoiditis, Neuralgia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡